Pricer AB (publ)
Pricer AB (publ) (PCRBF) Stock Competitors & Peer Comparison
See (PCRBF) competitors and their performances in Stock Market.
Peer Comparison Table: Business Equipment & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PCRBF | $0.34 | +0.00% | 54.9M | 0.40 | $0.83 | N/A |
| FUJIY | $9.36 | +2.52% | 22.6B | 13.37 | $0.70 | +3.26% |
| FUJIF | $17.00 | -11.23% | 20.5B | 12.06 | $1.41 | +2.69% |
| BRTHF | $21.51 | +0.09% | 5.4B | 15.93 | $1.35 | +3.03% |
| RICOF | $8.63 | +0.00% | 4.9B | 13.08 | $0.66 | +3.02% |
| RICOY | $8.41 | +5.10% | 4.8B | 12.74 | $0.66 | +3.13% |
| BRTHY | $36.80 | +0.00% | 4.6B | 13.68 | $2.69 | +2.49% |
| KNCAF | $3.53 | +0.00% | 1.7B | -4.20 | -$0.84 | +1.85% |
| KNCAY | $6.03 | +0.00% | 1.7B | -3.57 | -$1.69 | +1.15% |
| OKAMF | $16.00 | +60.80% | 1.5B | 15.53 | $1.03 | +4.24% |
Stock Comparison
PCRBF vs FUJIY Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, FUJIY has a market cap of 22.6B. Regarding current trading prices, PCRBF is priced at $0.34, while FUJIY trades at $9.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas FUJIY's P/E ratio is 13.37. In terms of profitability, PCRBF's ROE is +0.01%, compared to FUJIY's ROE of +0.08%. Regarding short-term risk, PCRBF is less volatile compared to FUJIY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check FUJIY's competition here
PCRBF vs FUJIF Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, FUJIF has a market cap of 20.5B. Regarding current trading prices, PCRBF is priced at $0.34, while FUJIF trades at $17.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas FUJIF's P/E ratio is 12.06. In terms of profitability, PCRBF's ROE is +0.01%, compared to FUJIF's ROE of +0.10%. Regarding short-term risk, PCRBF is less volatile compared to FUJIF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check FUJIF's competition here
PCRBF vs BRTHF Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, BRTHF has a market cap of 5.4B. Regarding current trading prices, PCRBF is priced at $0.34, while BRTHF trades at $21.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas BRTHF's P/E ratio is 15.93. In terms of profitability, PCRBF's ROE is +0.01%, compared to BRTHF's ROE of +0.08%. Regarding short-term risk, PCRBF is less volatile compared to BRTHF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check BRTHF's competition here
PCRBF vs RICOF Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, RICOF has a market cap of 4.9B. Regarding current trading prices, PCRBF is priced at $0.34, while RICOF trades at $8.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas RICOF's P/E ratio is 13.08. In terms of profitability, PCRBF's ROE is +0.01%, compared to RICOF's ROE of +0.06%. Regarding short-term risk, PCRBF is less volatile compared to RICOF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check RICOF's competition here
PCRBF vs RICOY Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, RICOY has a market cap of 4.8B. Regarding current trading prices, PCRBF is priced at $0.34, while RICOY trades at $8.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas RICOY's P/E ratio is 12.74. In terms of profitability, PCRBF's ROE is +0.01%, compared to RICOY's ROE of +0.08%. Regarding short-term risk, PCRBF is less volatile compared to RICOY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check RICOY's competition here
PCRBF vs BRTHY Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, BRTHY has a market cap of 4.6B. Regarding current trading prices, PCRBF is priced at $0.34, while BRTHY trades at $36.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas BRTHY's P/E ratio is 13.68. In terms of profitability, PCRBF's ROE is +0.01%, compared to BRTHY's ROE of +0.08%. Regarding short-term risk, PCRBF is less volatile compared to BRTHY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check BRTHY's competition here
PCRBF vs KNCAF Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, KNCAF has a market cap of 1.7B. Regarding current trading prices, PCRBF is priced at $0.34, while KNCAF trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas KNCAF's P/E ratio is -4.20. In terms of profitability, PCRBF's ROE is +0.01%, compared to KNCAF's ROE of -0.03%. Regarding short-term risk, PCRBF and KNCAF have similar daily volatility (0.00).Check KNCAF's competition here
PCRBF vs KNCAY Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, KNCAY has a market cap of 1.7B. Regarding current trading prices, PCRBF is priced at $0.34, while KNCAY trades at $6.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas KNCAY's P/E ratio is -3.57. In terms of profitability, PCRBF's ROE is +0.01%, compared to KNCAY's ROE of -0.03%. Regarding short-term risk, PCRBF is less volatile compared to KNCAY. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check KNCAY's competition here
PCRBF vs OKAMF Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, OKAMF has a market cap of 1.5B. Regarding current trading prices, PCRBF is priced at $0.34, while OKAMF trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas OKAMF's P/E ratio is 15.53. In terms of profitability, PCRBF's ROE is +0.01%, compared to OKAMF's ROE of +0.13%. Regarding short-term risk, PCRBF is less volatile compared to OKAMF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check OKAMF's competition here
PCRBF vs GMOFF Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, GMOFF has a market cap of 1B. Regarding current trading prices, PCRBF is priced at $0.34, while GMOFF trades at $125.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas GMOFF's P/E ratio is 304.88. In terms of profitability, PCRBF's ROE is +0.01%, compared to GMOFF's ROE of N/A. Regarding short-term risk, PCRBF and GMOFF have similar daily volatility (0.00).Check GMOFF's competition here
PCRBF vs PXGYF Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, PXGYF has a market cap of 506.4M. Regarding current trading prices, PCRBF is priced at $0.34, while PXGYF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas PXGYF's P/E ratio is 5.30. In terms of profitability, PCRBF's ROE is +0.01%, compared to PXGYF's ROE of +0.10%. Regarding short-term risk, PCRBF is less volatile compared to PXGYF. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check PXGYF's competition here
PCRBF vs NHBAF Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, NHBAF has a market cap of 258.5M. Regarding current trading prices, PCRBF is priced at $0.34, while NHBAF trades at $12.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas NHBAF's P/E ratio is 23.96. In terms of profitability, PCRBF's ROE is +0.01%, compared to NHBAF's ROE of +0.04%. Regarding short-term risk, PCRBF and NHBAF have similar daily volatility (0.00).Check NHBAF's competition here
PCRBF vs ADDC Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, ADDC has a market cap of 24.6M. Regarding current trading prices, PCRBF is priced at $0.34, while ADDC trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas ADDC's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to ADDC's ROE of N/A. Regarding short-term risk, PCRBF and ADDC have similar daily volatility (0.00).Check ADDC's competition here
PCRBF vs SORT Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, SORT has a market cap of 17.2M. Regarding current trading prices, PCRBF is priced at $0.34, while SORT trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas SORT's P/E ratio is -2.82. In terms of profitability, PCRBF's ROE is +0.01%, compared to SORT's ROE of +0.28%. Regarding short-term risk, PCRBF is less volatile compared to SORT. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check SORT's competition here
PCRBF vs TLCO Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, TLCO has a market cap of 2M. Regarding current trading prices, PCRBF is priced at $0.34, while TLCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas TLCO's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to TLCO's ROE of N/A. Regarding short-term risk, PCRBF is less volatile compared to TLCO. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check TLCO's competition here
PCRBF vs PCST Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, PCST has a market cap of 393.5K. Regarding current trading prices, PCRBF is priced at $0.34, while PCST trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas PCST's P/E ratio is -20.60. In terms of profitability, PCRBF's ROE is +0.01%, compared to PCST's ROE of +0.28%. Regarding short-term risk, PCRBF and PCST have similar daily volatility (0.00).Check PCST's competition here
PCRBF vs TCHH Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, TCHH has a market cap of 144.8K. Regarding current trading prices, PCRBF is priced at $0.34, while TCHH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas TCHH's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to TCHH's ROE of +1.43%. Regarding short-term risk, PCRBF is less volatile compared to TCHH. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check TCHH's competition here
PCRBF vs RBSY Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, RBSY has a market cap of 5.3K. Regarding current trading prices, PCRBF is priced at $0.34, while RBSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas RBSY's P/E ratio is -0.01. In terms of profitability, PCRBF's ROE is +0.01%, compared to RBSY's ROE of +0.94%. Regarding short-term risk, PCRBF and RBSY have similar daily volatility (0.00).Check RBSY's competition here
PCRBF vs KARE Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, KARE has a market cap of 1.4K. Regarding current trading prices, PCRBF is priced at $0.34, while KARE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas KARE's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to KARE's ROE of -1.59%. Regarding short-term risk, PCRBF is less volatile compared to KARE. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check KARE's competition here
PCRBF vs CHMP Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, CHMP has a market cap of 1.1K. Regarding current trading prices, PCRBF is priced at $0.34, while CHMP trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas CHMP's P/E ratio is -1.00. In terms of profitability, PCRBF's ROE is +0.01%, compared to CHMP's ROE of -0.49%. Regarding short-term risk, PCRBF is less volatile compared to CHMP. This indicates potentially lower risk in terms of short-term price fluctuations for PCRBF.Check CHMP's competition here
PCRBF vs GPTX Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, GPTX has a market cap of 771. Regarding current trading prices, PCRBF is priced at $0.34, while GPTX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas GPTX's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to GPTX's ROE of -0.91%. Regarding short-term risk, PCRBF and GPTX have similar daily volatility (0.00).Check GPTX's competition here
PCRBF vs PRNI Comparison May 2026
PCRBF plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PCRBF stands at 54.9M. In comparison, PRNI has a market cap of 0. Regarding current trading prices, PCRBF is priced at $0.34, while PRNI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PCRBF currently has a P/E ratio of 0.40, whereas PRNI's P/E ratio is N/A. In terms of profitability, PCRBF's ROE is +0.01%, compared to PRNI's ROE of N/A. Regarding short-term risk, PCRBF and PRNI have similar daily volatility (0.00).Check PRNI's competition here